TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (ARCH:CA), (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the University Health Network Research ...

Acute kidney injury (AKI), previously called acute renal failure, is when the kidneys are suddenly unable to filter waste products from the blood. This condition can develop slowly or quickly, and ...

AKI can be classified as prerenal, intrinsic, or postrenal, with KDIGO criteria guiding diagnosis. New biomarkers like NGAL and cystatin C allow earlier and more precise detection of AKI. Preventing ...

Acute kidney injury (AKI) is a severe renal disorder affecting approximately 10%-15% of hospitalized patients and up to 50% in intensive care units (ICUs). Its pathogenesis involves complex ...

New guidance from the American Society of Nephrology (ASN) addresses needed improvements in providing appropriate care to patients discharged after experiencing acute kidney injury requiring ...

The published data complement a recent review from the Mayo Clinic that highlights penKid's potential as a new method to measure renal function beyond creatinine (2). Acute kidney injury (AKI) is a ...

SeaStar Medical Holding Corp. shares rose 7% to their highest level in more than three months on Wednesday after the company said an independent safety board had reviewed early data and recommended ...

Compared with no treatment, aspirin use was associated with an increased risk for acute kidney injury (AKI) in critical patients with chest trauma, a new cohort study revealed. Nonsteroidal ...

The CS-AKI Phase II trial is an international multi-center, randomized, double-blind, placebo-controlled study of LSALT peptide with a recruitment target of 240 patients. The primary objective of the ...